Tiziana life sciences ceo discusses covid-19 trial data in exclusive interview

New york and london, feb. 03, 2021 (globe newswire) -- tiziana life sciences plc (nasdaq:tlsa/lse:tils) ("tiziana" or the "company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announced an interview with dr. kunwar shailubhai, ceo and cso, is now available.

TLSA Ratings Summary

TLSA Quant Ranking